Should You Buy Bristol-Myers Squibb Co (BMY) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast BMY stock price to fall
20 Analyst Rating
Wall Street analysts forecast BMY stock price to fall
8 Buy
11 Hold
1 Sell
Moderate Buy
Current: 56.910
Low
37
Averages
55.86
High
68
Current: 56.910
Low
37
Averages
55.86
High
68
Citi
Neutral
maintain
$64 -> $66
AI Analysis
2026-05-01
Reason
Citi
Price Target
$64 -> $66
AI Analysis
2026-05-01
maintain
Neutral
Reason
Citi raised the firm's price target on Bristol Myers to $66 from $64 and keeps a Neutral rating on the shares. The firm updated the company's model post the Q1 report.
BofA
Jason Gerberry
Buy
to
Buy
downgrade
$68 -> $67
2026-04-09
Reason
BofA
Jason Gerberry
Price Target
$68 -> $67
2026-04-09
downgrade
Buy
to
Buy
Reason
BofA analyst Jason Gerberry lowered the firm's price target on Bristol Myers to $67 from $68 and keeps a Buy rating on the shares. The firm adjusted several targets in conjunction with its Q1 preview for its large-cap pharma and small-to-mid cap biopharma coverage.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BMY
